DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1Dr. Reddy's Laboratories
02 1AVIR PHARMA INC.
03 1Accord healthcare
04 2Apotex Inc
05 1Arrotex Pharmaceuticals
06 1Aurobindo Pharma Limited
07 2Baxter Healthcare Corporation
08 1FORMATIVE PHARMA INC.
09 1Flagship Biotech International Pvt. Ltd
10 1Fresenius Kabi Austria
11 1Fresenius Kabi USA
12 1Hainan Poly Pharm
13 1Hainan Shuangcheng Pharmaceuticals
14 2Hospira, Inc.
15 1JUNO PHARMACEUTICALS CORP.
16 1Jodas Expoim Pvt. Ltd
17 1Laboratorio Reig Jofre SA
18 1Maia Pharmaceuticals
19 1Meitheal Pharmaceuticals
20 1Pliva Hrvatska
21 2Sandoz B2B
22 1Slate Run Pharmaceuticals
23 1Stanex Drugs and Chemicals
24 1THE MEDICINES COMPANY UK LTD
25 2The Medic Ines Company UK Ltd
26 1The Medicines Company UK Ltd,
27 2Viatris
01 1Bivalirudin 250Mg 10 Units Parenteral Use
02 1INJECTABLE;INJECTION
03 13INJECTABLE;INTRAVENOUS
04 3Injection
05 1Lyo.Inj
06 2POWDER FOR CONCENTRATE FOR SOLUTION FOR INJECTION
07 4POWDER FOR SOLUTION
08 2Powder to concentrate to the Injection/infusion fluid, resolution
09 1SOLUTION
10 3SOLUTION;INTRAVENOUS
11 2Blank
01 5DISCN
02 2Generic
03 5Prescription
04 10RX
05 11Blank
01 2ANGIOMAX
02 1ANGIOMAX RTU
03 4Angiox
04 13BIVALIRUDIN
05 1BIVALIRUDIN ARX
06 3BIVALIRUDIN FOR INJECTION
07 2BIVALIRUDIN IN 0.9% SODIUM CHLORIDE
08 1BIVALIRUDIN INJECTION
09 1Bivalirudin APOTEX
10 1Bivalirudin Reig Jofre
11 4Blank
01 2Australia
02 5Canada
03 1China
04 3India
05 1Italy
06 2Norway
07 2Sweden
08 17USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : BIVALIRUDIN
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : 250MG/VIAL
Packaging :
Approval Date : 2017-05-26
Application Number : 201577
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : BIVALIRUDIN
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : 250MG/VIAL
Packaging :
Approval Date : 2017-11-22
Application Number : 206551
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BIVALIRUDIN
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : 250MG/VIAL
Packaging :
Approval Date : 2017-07-06
Application Number : 204876
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : BIVALIRUDIN
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : 250MG/VIAL
Packaging :
Approval Date : 2018-07-27
Application Number : 205962
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BIVALIRUDIN IN 0.9% SODIUM CHLORIDE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 250MG/50ML (5MG/ML)
Packaging :
Approval Date : 2017-12-21
Application Number : 208374
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BIVALIRUDIN IN 0.9% SODIUM CHLORIDE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 500MG/100ML (5MG/ML)
Packaging :
Approval Date : 2017-12-21
Application Number : 208374
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : Generic
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 250MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Regulatory Info : RX
Registration Country : USA
Brand Name : BIVALIRUDIN
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : 250MG/VIAL
Packaging :
Approval Date : 2016-10-28
Application Number : 90189
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : BIVALIRUDIN
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : 250MG/VIAL
Packaging :
Approval Date : 2019-10-23
Application Number : 210031
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BIVALIRUDIN
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : 250MG/VIAL
Packaging :
Approval Date : 2015-07-14
Application Number : 90811
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BIVALIRUDIN
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : 250MG/VIAL
Packaging :
Approval Date : 2015-07-14
Application Number : 90816
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ANGIOMAX RTU
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 250MG/50ML (5MG/ML)
Packaging :
Approval Date : 2019-07-25
Application Number : 211215
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : BIVALIRUDIN
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : 250MG/VIAL
Packaging :
Approval Date : 2018-07-16
Application Number : 91602
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : BIVALIRUDIN
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : 250MG/VIAL
Packaging :
Approval Date :
Application Number : 91206
Regulatory Info :
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ANGIOMAX
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : 250MG/VIAL
Packaging :
Approval Date : 2000-12-15
Application Number : 20873
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : BIVALIRUDIN
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : 250MG/VIAL
Packaging :
Approval Date : 2021-05-28
Application Number : 213078
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : BIVALIRUDIN
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 250MG/VIAL
Packaging :
Approval Date :
Application Number : 91468
Regulatory Info :
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : BIVALIRUDIN
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : 250MG/VIAL
Packaging :
Approval Date : 2018-06-01
Application Number : 202471
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Sweden
Brand Name : Angiox
Dosage Form : POWDER FOR CONCENTRATE FOR SOLUTION FOR INJECTION
Dosage Strength : 250 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Sweden
Brand Name : Bivalirudin Reig Jofre
Dosage Form : POWDER FOR CONCENTRATE FOR SOLUTION FOR INJECTION
Dosage Strength : 250 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
